Correction: Mertz et al. Interdisciplinary Animal Research Ethics-Challenges, Opportunities, and Perspectives. <i>Animals</i> 2024, <i>14</i>, 2896. [PDF]
Mertz M+13 more
europepmc +1 more source
Directivity of the String Instruments and its Influence on the Orchestra Sound in Concert Halls
Jürgen Meyer
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
Cultural interplay in end-of-life care decisions: comparing advance directive beliefs and preferences among adults in the U.S. and Taiwan. [PDF]
Chen DR+4 more
europepmc +1 more source
5'-O-Trityl Group Promoted Directive Effect in the Preparation of 2'-O-Methylribonucleosides. [PDF]
Jarmo Heikkilä+4 more
openalex +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Regulatory aspects of optogenetic research and therapy for retinitis pigmentosa under EU law. [PDF]
Freise J.
europepmc +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
The Possibility of Health Care Directives for Vaccinations-A Consultation Study With Relevant Stakeholders. [PDF]
Porter MM, Shariff MJ.
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source